On July 21, 2025, Cingulate Inc. entered a deal to sell up to $25 million of its common stock to Lincoln Park Capital, with an initial issuance of 120,424 shares as part of the agreement. The proceeds are intended for regulatory approval, development, and general corporate purposes.